BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 1520354
Paris, I0
Position in IRWD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,579,962
+$262,702 QoQ
Shares Held
375,288
0.0% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 212 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $480,515,408 across 25 Drug Manufacturers - Specialty & Generic names. IRWD ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,494,259 | $251,842,409 | |
| 2 | ZTS |
Zoetis Inc.
|
1,173,974 | $84,361,770 | |
| 3 | ALKS |
Alkermes plc.
|
1,159,216 | $60,742,916 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
976,103 | $33,070,368 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
44,851 | $24,301,615 | |
| 6 | VTRS |
Viatris Inc
|
828,396 | $13,154,927 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,458 | $3,875,610 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
72,383 | $3,421,543 |
All Filings in IRWD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,579,962 | 375,288 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,317,260 | 375,288 | Shares | Defined | 2026-05-14 | |
| 2020-06-30 | $13,052,694 | 1,264,796 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $19,167,064 | 1,899,610 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||